Skip to main content

Nea ɛsɛ sɛ wuhu fa Inebilizumab aduru a wɔde sa Neuromyelitis Optica Spectrum Disorder (NMOSD) ho .

Nea ɛsɛ sɛ wuhu fa Inebilizumab aduru a wɔde sa Neuromyelitis Optica Spectrum Disorder (NMOSD) ho .

So wo anaa obi a wunim no wɔ Neuromyelitis Optica Spectrum Disorder (NMOSD)? Sɛ saa a, ebia wo duruyɛfo aka aduru bi a wɔfrɛ no Inebilizumab (wɔbɔ no: ee-ne-bi-li-su-mab) ho asɛm akyerɛ wo. Edin a ɛte saa a wobɛte no betumi ayɛ hu kakra. Nanso mma ɛnhaw wo. Ɛnnɛ, yɛbɛka saa aduru yi ho asɛm, nea ɛyɛ, ne nea ɛsɛ sɛ wohwɛ yiye wɔ ho bere a wode redi dwuma no.

Enti, dɛn ne aduru yi a wɔfrɛ no Inebilizumab?

Sɛ yɛbɛka no tiawa a, `Inebilizumab` (ahyɛnsode din: UPLIZNA) yɛ protein pɔtee bi. Wɔ aduruyɛ ho nyansahu mu no, yɛfrɛ eyi `monoclonal antibody`. Ne dwumadie titire ne sɛ ɛbɛdi yareɛ tebea `Neuromyelitis Optica Spectrum Disorder (NMOSD)` so.

NMOSD yɛ tebea a yɛn nipadua mu tumi a ɛko tia nyarewa no tow hyɛ n’ankasa ntini mu nkwammoaa so, titiriw nea ɛwɔ aniwa ne akyi berɛmo mu no. Enti nea saa aduru `Inebilizumab` yi yɛ ne sɛ ɛde n’ani si saa nipadua no mu tumi a ɛko tia nyarewa a ɛnteɛ no so, gyae, na ɛtew ɔsɛe a yare no de ba no so.

Ebia wo duruyɛfo nso bɛkyerɛw saa aduru yi ama wo wɔ tebea afoforo ho, enti sɛ wowɔ biribi a ɛhaw wo a, yɛsrɛ wo bisa wo duruyɛfo no ho asɛm.

Nneɛma a ɛsɛ sɛ woka kyerɛ wo duruyɛfo ansa na woafi ase anom nnuru

Ansa na wubefi saa ayaresa yi ase no, ɛho hia yiye sɛ wobɔ wo duruyɛfo amanneɛ wɔ w’akwahosan ho abakɔsɛm a edi mũ ho. Titiriw no, akyinnye biara nni ho sɛ ɛsɛ sɛ woka nsɛntitiriw a edidi so yi ho asɛm kyerɛ no.

Nea ɛsɛ sɛ wuhu Dɛn nti na ɛte saa? (Nea ɛte saa ara) .
Nkwammoaa a ɛko tia nyarewa ho haw ahorow: Sɛ wowɔ nipadua mu ahoɔden a ɛko tia nyarewa no mmerɛwyɛ afoforo a. Esiane sɛ saa aduru yi sesa sɛnea nipadua no mu tumi a ɛko tia nyarewa no yɛ adwuma nti, ɛho hia sɛ wuhu ɔhaw biara a ɛwɔ hɔ dedaw.
Mprempren nyarewa: Sɛ wowɔ atiridiinini, atiridiinini, ɔfe, anaa ɔyare mmoawa te sɛ akisikuru anaa akisikuru a.Saa aduru yi brɛ tumi a wutumi ko tia nyarewa no ase, enti ɔyare mmoawa bi a ɛwɔ hɔ dedaw no betumi asɛe kɛse.
Allergies: Sɛ wowɔ allergies wɔ Inebilizumab anaa nnuru afoforo, nnuan, anaa nnuru a wɔde yɛ nneɛma ho a. Eyi ho hia na wɔasiw akisikuru a emu yɛ den a ebetumi aba bere a wɔde aduru no ama no ano.
Nyinsɛn: Sɛ woanyinsɛn, worebɔ mmɔden sɛ wubenyinsɛn, anaa worema nufu a. Saa aduru yi betumi apira akokoaa a ɔwɔ awotwaa mu no, enti ɛho hia paa sɛ yɛbɛka eyi ho asɛm.

Mɛyɛ dɛn ama wo aduru yi?

``Inebilizumab`` nyɛ aduru a wobɛnom wɔ fie. Ɛyɛ aduru a wɔde fa ntini bi mu a wɔde nkyene (a wɔde fa ntini mu) gu mu . Wɔde saa ayaresa yi ma wɔ ayaresabea anaa ayaresabea bi a nnuruyɛfo a wɔatete wɔn hwɛ so.

Ansa na wɔbɛsa wo yare no, wobetumi ama wo nnuru afoforo (sɛ nhwɛso no, nnuru a ɛma wo ho yɛ wo hyew) na ama asiane a ɛwɔ hɔ sɛ wo ho bɛtɔ wo wɔ aduru no ho no so atew.

Ansa na ayaresa biara bɛba no, wɔbɛma wo nsɛm kratasin titiriw bi (`MedGuide`) a ɛfa saa aduru yi ho. Ɛho hia sɛ wokenkan na wote ase yiye bere biara.

Na sɛ aduru no dodow kɔ soro nso ɛ?

Wɔde eyi ma wɔ ayaresabea, enti hokwan a ɛwɔ hɔ sɛ eyi bɛba no sua koraa. Nanso, sɛ wususuw sɛ woanom aduru no pii a, ka kyerɛ nnuruyɛfo no ntɛm ara. Sɛ ɛnte saa a, frɛ Ɔman Awuduru Ho Amanneɛbɔbea a ɛwɔ Colombo Ɔman Ayaresabea no . Anaasɛ kɔ ayaresabea a ɛbɛn wo no Emergency Treatment Unit (ETU) .

Na sɛ mepa da a mɛnom aduru no nso ɛ?

Wɔde saa ayaresa yi ma wɔ nhyehyɛe a wɔahyɛ da ayɛ mu. Enti, ɛho hia paa sɛ wonya ayaresa wɔ bere ano. Sɛ biribi nti wuntumi nkɔ da a woahyɛ da ato hɔ no a, frɛ wo duruyɛfo anaa ayaresabea ntɛm ara na ma wɔnhu, sɛnea ɛbɛyɛ a wobetumi ayɛ nhyehyɛe ama da a edi hɔ a ɛwɔ hɔ no.

Nneɛma a ɛsɛ sɛ wohwɛ yiye wɔ ho titiriw bere a worenom aduru no

Wo duruyɛfo bɛhwɛ wo yiye bere a worenom aduru yi, na ɛho hia sɛ wuhu saa nneɛma yi.

  • Asiane a ɛwɔ hɔ sɛ wubenya ɔyare mmoawa: Esiane sɛ saa aduru yi siw wo nipadua no mu tumi a ɛko tia nyarewa ano kodu baabi nti, ebia asiane a ɛwɔ hɔ sɛ wubenya ɔyare mmoawa no ayɛ kɛse . Sɛ wunya ɔyare no ho sɛnkyerɛnne biara te sɛ atiridiinini, atiridiinini, menewam yaw, ɔfe, atiridiinini ho sɛnkyerɛnne, anaa ɛyaw bere a woretow nsu a, .Ka kyerɛ wo duruyɛfo ntɛm ara. Mma nnyɛ wo ho aduru. Bɔ mmɔden sɛ wobɛtwe wo ho afi ayarefo ho.
  • Nneɛma a ɛma obi ho yɛ no hyew a emu yɛ den: Ebia nnipa binom ho yɛ wɔn yaw kɛse wɔ aduru yi ho. Sɛ wo honam ani yɛ wo yaw, wo ho yɛ wo yaw, w’anim, w’ano, anaa wo tɛkrɛma ho ahonhon bere a worehyɛ wo aduru no mu anaasɛ bere tiaa bi akyi a, bɔ nnuruyɛfo amanneɛ ntɛm ara.
  • Nyinsɛn a wobɛkwati: Sɛ woyɛ ɔbea a, kwati sɛ wubenyinsɛn bere a worenom aduru yi ne asram 6 bere a woagyae ayaresa no akyi . Saa aduru yi betumi apira akokoaa a ɔhyɛ yafunu mu kɛse. Sɛ woreyɛ nhyehyɛe sɛ wubenyinsɛn a, wo ne wo duruyɛfo nka ho asɛm.

Hyɛ no nsow titiriw: Ɛntaa mma sɛ saa aduru yi betumi ama amemene no mu yare a emu yɛ den a ɛde nkwa to asiane mu (a wɔfrɛ no `Progressive Multifocal Leukoencephalopathy - PML`) wɔ nnipa binom mu. Enti, sɛ wuhyia ɔhaw anaa nsakrae biara wɔ w’ani, wo nsusuwii, wo kasa, wo nantew, anaa wo kari pɛ mu , ka kyerɛ wo duruyɛfo ntɛm ara .

Nsunsuanso bɔne a aduru no de ba

Te sɛ aduru biara no, `Inebilizumab` betumi de nsunsuanso bɔne bi aba. Ɛsɛ sɛ wɔbɔ eyinom bi ho amanneɛ ntɛm ara, bere a afoforo nso nyɛ aniberesɛm saa.

Nsunsuanso bɔne a ɛsɛ sɛ wobɔ wo duruyɛfo amanneɛ ntɛm ara
Nneɛma a ɛma obi ho yɛ no hyew a emu yɛ den Wora mu akisikuru, ɛyaw, anim, anofafa, tɛkrɛma a ɛho ahonhon, ɛyɛ den sɛ wobɛhome.
Nsɛnkyerɛnne a ɛkyerɛ sɛ obi anya ɔyare mmoawa Atiridiinini, atiridiinini, menewam yaw, ɔfe, nsu mu yare.
Mpɛn pii no ɛnyɛ aniberesɛm (nanso sɛ ɛkɔ so a, ka kyerɛ wo duruyɛfo ) .
Nipadua mu yaw Akyi yaw, nkwaa mu yaw.
Tipaeɛ Tiyɛ a ɛnyɛ den kosi nea ɛkɔ fam.
Ɛnyɛ ahotɔ wɔ baabi a wɔde injection no Ɛyaw, kɔkɔɔ, anaa ɔfe wɔ baabi a wɔde aduru no guu no.

Saa nsɛm a wɔahyehyɛ yi nka nsunsuanso bɔne a ebetumi aba nyinaa ho. Bio nso, sɛ wuhyia biribi a ɛyɛ soronko a, wo ne wo duruyɛfo nka ho asɛm.

Nkrasɛm a Wɔde Kɔ Fie

  • `Inebilizumab` yɛ aduru pɔtee bi a wɔde fa ntini bi so ma wɔ ayaresabea ma `Neuromyelitis Optica Spectrum Disorder (NMOSD).`
  • Ansa na wubefi ayaresa ase no, ka w’ayaresa mu tebea horow, wo ho akisikuru, ne nnuru afoforo a wonom nyinaa ho asɛm kyerɛ wo duruyɛfo.
  • Sɛ wunya ɔyare mmoawa ho sɛnkyerɛnne te sɛ atiridiinini ne ɔfe bere a worenom aduru yi a, hwehwɛ aduruyɛfo afotu ntɛm ara.
  • Kwati sɛ wubenyinsɛn bere a woresa yare no ne asram 6 bere a woagyae no akyi. Wo ne wo duruyɛfo nka eyi ho asɛm.
  • Nsuro sɛ wobɛsrɛ wo duruyɛfo sɛ ɔmma wo nkyerɛkyerɛmu wɔ ɔhaw anaa adwenem naayɛ biara a ebia wowɔ ho. Wɔwɔ hɔ sɛ wɔbɛboa wo.

Inebilizumab, UPLIZNA, Neuromyelitis Optica, NMOSD, monoclonal antibody, nea efi mu ba, Inebilizumab, vaccine, ntini mu yare, nea efi mu ba, ayaresa, NMOSD aduru

Frequently Asked Questions (FAQ)

Na sɛ mepa da a mɛnom aduru no nso ɛ?

Wɔde saa ayaresa yi ma wɔ nhyehyɛe a wɔahyɛ da ayɛ mu. Enti, ɛho hia paa sɛ wonya ayaresa wɔ bere ano. Sɛ biribi nti wuntumi nkɔ da a woahyɛ da ato hɔ no a, frɛ wo duruyɛfo anaa ayaresabea ntɛm ara na ma wɔnhu, sɛnea ɛbɛyɛ a wobetumi ayɛ nhyehyɛe ama da a edi hɔ a ɛwɔ hɔ no.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Wɔnnya nyɛɛ nsɛm biara. Fa wo nsɛm no ka ho wɔ ha nea edi kan.

Fa wo nsɛm no ka ho

Yɛsrɛ wo bu akontaa: 1 + 5 =
Nea ɛsɛ sɛ wuhu fa Inebilizumab aduru a wɔde sa Neuromyelitis Optica Spectrum Disorder (NMOSD) ho .
Nnuru a wɔde di dwuma6, Kutawonsa, 2026

Nea ɛsɛ sɛ wuhu fa Inebilizumab aduru a wɔde sa Neuromyelitis Optica Spectrum Disorder (NMOSD) ho .

So wo anaa obi a wunim no wɔ Neuromyelitis Optica Spectrum Disorder (NMOSD)? Sɛ saa a, ebia wo duruyɛfo aka aduru bi a wɔfrɛ no Inebilizumab (wɔbɔ no: ee-ne-bi-li-su-mab) ho asɛm akyerɛ wo. Edin a ɛte saa a wobɛte no betumi ayɛ hu kakra. Nanso mma ɛnhaw wo. Ɛnnɛ, yɛbɛka saa aduru yi ho asɛm, nea ɛyɛ, ne nea ɛsɛ sɛ wohwɛ yiye wɔ ho bere a wode redi dwuma no.

Enti, dɛn ne aduru yi a wɔfrɛ no Inebilizumab?

Sɛ yɛbɛka no tiawa a, `Inebilizumab` (ahyɛnsode din: UPLIZNA) yɛ protein pɔtee bi. Wɔ aduruyɛ ho nyansahu mu no, yɛfrɛ eyi `monoclonal antibody`. Ne dwumadie titire ne sɛ ɛbɛdi yareɛ tebea `Neuromyelitis Optica Spectrum Disorder (NMOSD)` so.

NMOSD yɛ tebea a yɛn nipadua mu tumi a ɛko tia nyarewa no tow hyɛ n’ankasa ntini mu nkwammoaa so, titiriw nea ɛwɔ aniwa ne akyi berɛmo mu no. Enti nea saa aduru `Inebilizumab` yi yɛ ne sɛ ɛde n’ani si saa nipadua no mu tumi a ɛko tia nyarewa a ɛnteɛ no so, gyae, na ɛtew ɔsɛe a yare no de ba no so.

Ebia wo duruyɛfo nso bɛkyerɛw saa aduru yi ama wo wɔ tebea afoforo ho, enti sɛ wowɔ biribi a ɛhaw wo a, yɛsrɛ wo bisa wo duruyɛfo no ho asɛm.

Nneɛma a ɛsɛ sɛ woka kyerɛ wo duruyɛfo ansa na woafi ase anom nnuru

Ansa na wubefi saa ayaresa yi ase no, ɛho hia yiye sɛ wobɔ wo duruyɛfo amanneɛ wɔ w’akwahosan ho abakɔsɛm a edi mũ ho. Titiriw no, akyinnye biara nni ho sɛ ɛsɛ sɛ woka nsɛntitiriw a edidi so yi ho asɛm kyerɛ no.

Nea ɛsɛ sɛ wuhu Dɛn nti na ɛte saa? (Nea ɛte saa ara) .
Nkwammoaa a ɛko tia nyarewa ho haw ahorow: Sɛ wowɔ nipadua mu ahoɔden a ɛko tia nyarewa no mmerɛwyɛ afoforo a. Esiane sɛ saa aduru yi sesa sɛnea nipadua no mu tumi a ɛko tia nyarewa no yɛ adwuma nti, ɛho hia sɛ wuhu ɔhaw biara a ɛwɔ hɔ dedaw.
Mprempren nyarewa: Sɛ wowɔ atiridiinini, atiridiinini, ɔfe, anaa ɔyare mmoawa te sɛ akisikuru anaa akisikuru a.Saa aduru yi brɛ tumi a wutumi ko tia nyarewa no ase, enti ɔyare mmoawa bi a ɛwɔ hɔ dedaw no betumi asɛe kɛse.
Allergies: Sɛ wowɔ allergies wɔ Inebilizumab anaa nnuru afoforo, nnuan, anaa nnuru a wɔde yɛ nneɛma ho a. Eyi ho hia na wɔasiw akisikuru a emu yɛ den a ebetumi aba bere a wɔde aduru no ama no ano.
Nyinsɛn: Sɛ woanyinsɛn, worebɔ mmɔden sɛ wubenyinsɛn, anaa worema nufu a. Saa aduru yi betumi apira akokoaa a ɔwɔ awotwaa mu no, enti ɛho hia paa sɛ yɛbɛka eyi ho asɛm.

Mɛyɛ dɛn ama wo aduru yi?

``Inebilizumab`` nyɛ aduru a wobɛnom wɔ fie. Ɛyɛ aduru a wɔde fa ntini bi mu a wɔde nkyene (a wɔde fa ntini mu) gu mu . Wɔde saa ayaresa yi ma wɔ ayaresabea anaa ayaresabea bi a nnuruyɛfo a wɔatete wɔn hwɛ so.

Ansa na wɔbɛsa wo yare no, wobetumi ama wo nnuru afoforo (sɛ nhwɛso no, nnuru a ɛma wo ho yɛ wo hyew) na ama asiane a ɛwɔ hɔ sɛ wo ho bɛtɔ wo wɔ aduru no ho no so atew.

Ansa na ayaresa biara bɛba no, wɔbɛma wo nsɛm kratasin titiriw bi (`MedGuide`) a ɛfa saa aduru yi ho. Ɛho hia sɛ wokenkan na wote ase yiye bere biara.

Na sɛ aduru no dodow kɔ soro nso ɛ?

Wɔde eyi ma wɔ ayaresabea, enti hokwan a ɛwɔ hɔ sɛ eyi bɛba no sua koraa. Nanso, sɛ wususuw sɛ woanom aduru no pii a, ka kyerɛ nnuruyɛfo no ntɛm ara. Sɛ ɛnte saa a, frɛ Ɔman Awuduru Ho Amanneɛbɔbea a ɛwɔ Colombo Ɔman Ayaresabea no . Anaasɛ kɔ ayaresabea a ɛbɛn wo no Emergency Treatment Unit (ETU) .

Na sɛ mepa da a mɛnom aduru no nso ɛ?

Wɔde saa ayaresa yi ma wɔ nhyehyɛe a wɔahyɛ da ayɛ mu. Enti, ɛho hia paa sɛ wonya ayaresa wɔ bere ano. Sɛ biribi nti wuntumi nkɔ da a woahyɛ da ato hɔ no a, frɛ wo duruyɛfo anaa ayaresabea ntɛm ara na ma wɔnhu, sɛnea ɛbɛyɛ a wobetumi ayɛ nhyehyɛe ama da a edi hɔ a ɛwɔ hɔ no.

Nneɛma a ɛsɛ sɛ wohwɛ yiye wɔ ho titiriw bere a worenom aduru no

Wo duruyɛfo bɛhwɛ wo yiye bere a worenom aduru yi, na ɛho hia sɛ wuhu saa nneɛma yi.

  • Asiane a ɛwɔ hɔ sɛ wubenya ɔyare mmoawa: Esiane sɛ saa aduru yi siw wo nipadua no mu tumi a ɛko tia nyarewa ano kodu baabi nti, ebia asiane a ɛwɔ hɔ sɛ wubenya ɔyare mmoawa no ayɛ kɛse . Sɛ wunya ɔyare no ho sɛnkyerɛnne biara te sɛ atiridiinini, atiridiinini, menewam yaw, ɔfe, atiridiinini ho sɛnkyerɛnne, anaa ɛyaw bere a woretow nsu a, .Ka kyerɛ wo duruyɛfo ntɛm ara. Mma nnyɛ wo ho aduru. Bɔ mmɔden sɛ wobɛtwe wo ho afi ayarefo ho.
  • Nneɛma a ɛma obi ho yɛ no hyew a emu yɛ den: Ebia nnipa binom ho yɛ wɔn yaw kɛse wɔ aduru yi ho. Sɛ wo honam ani yɛ wo yaw, wo ho yɛ wo yaw, w’anim, w’ano, anaa wo tɛkrɛma ho ahonhon bere a worehyɛ wo aduru no mu anaasɛ bere tiaa bi akyi a, bɔ nnuruyɛfo amanneɛ ntɛm ara.
  • Nyinsɛn a wobɛkwati: Sɛ woyɛ ɔbea a, kwati sɛ wubenyinsɛn bere a worenom aduru yi ne asram 6 bere a woagyae ayaresa no akyi . Saa aduru yi betumi apira akokoaa a ɔhyɛ yafunu mu kɛse. Sɛ woreyɛ nhyehyɛe sɛ wubenyinsɛn a, wo ne wo duruyɛfo nka ho asɛm.

Hyɛ no nsow titiriw: Ɛntaa mma sɛ saa aduru yi betumi ama amemene no mu yare a emu yɛ den a ɛde nkwa to asiane mu (a wɔfrɛ no `Progressive Multifocal Leukoencephalopathy - PML`) wɔ nnipa binom mu. Enti, sɛ wuhyia ɔhaw anaa nsakrae biara wɔ w’ani, wo nsusuwii, wo kasa, wo nantew, anaa wo kari pɛ mu , ka kyerɛ wo duruyɛfo ntɛm ara .

Nsunsuanso bɔne a aduru no de ba

Te sɛ aduru biara no, `Inebilizumab` betumi de nsunsuanso bɔne bi aba. Ɛsɛ sɛ wɔbɔ eyinom bi ho amanneɛ ntɛm ara, bere a afoforo nso nyɛ aniberesɛm saa.

Nsunsuanso bɔne a ɛsɛ sɛ wobɔ wo duruyɛfo amanneɛ ntɛm ara
Nneɛma a ɛma obi ho yɛ no hyew a emu yɛ den Wora mu akisikuru, ɛyaw, anim, anofafa, tɛkrɛma a ɛho ahonhon, ɛyɛ den sɛ wobɛhome.
Nsɛnkyerɛnne a ɛkyerɛ sɛ obi anya ɔyare mmoawa Atiridiinini, atiridiinini, menewam yaw, ɔfe, nsu mu yare.
Mpɛn pii no ɛnyɛ aniberesɛm (nanso sɛ ɛkɔ so a, ka kyerɛ wo duruyɛfo ) .
Nipadua mu yaw Akyi yaw, nkwaa mu yaw.
Tipaeɛ Tiyɛ a ɛnyɛ den kosi nea ɛkɔ fam.
Ɛnyɛ ahotɔ wɔ baabi a wɔde injection no Ɛyaw, kɔkɔɔ, anaa ɔfe wɔ baabi a wɔde aduru no guu no.

Saa nsɛm a wɔahyehyɛ yi nka nsunsuanso bɔne a ebetumi aba nyinaa ho. Bio nso, sɛ wuhyia biribi a ɛyɛ soronko a, wo ne wo duruyɛfo nka ho asɛm.

Nkrasɛm a Wɔde Kɔ Fie

  • `Inebilizumab` yɛ aduru pɔtee bi a wɔde fa ntini bi so ma wɔ ayaresabea ma `Neuromyelitis Optica Spectrum Disorder (NMOSD).`
  • Ansa na wubefi ayaresa ase no, ka w’ayaresa mu tebea horow, wo ho akisikuru, ne nnuru afoforo a wonom nyinaa ho asɛm kyerɛ wo duruyɛfo.
  • Sɛ wunya ɔyare mmoawa ho sɛnkyerɛnne te sɛ atiridiinini ne ɔfe bere a worenom aduru yi a, hwehwɛ aduruyɛfo afotu ntɛm ara.
  • Kwati sɛ wubenyinsɛn bere a woresa yare no ne asram 6 bere a woagyae no akyi. Wo ne wo duruyɛfo nka eyi ho asɛm.
  • Nsuro sɛ wobɛsrɛ wo duruyɛfo sɛ ɔmma wo nkyerɛkyerɛmu wɔ ɔhaw anaa adwenem naayɛ biara a ebia wowɔ ho. Wɔwɔ hɔ sɛ wɔbɛboa wo.

Inebilizumab, UPLIZNA, Neuromyelitis Optica, NMOSD, monoclonal antibody, nea efi mu ba, Inebilizumab, vaccine, ntini mu yare, nea efi mu ba, ayaresa, NMOSD aduru

Frequently Asked Questions (FAQ)

Na sɛ mepa da a mɛnom aduru no nso ɛ?

Wɔde saa ayaresa yi ma wɔ nhyehyɛe a wɔahyɛ da ayɛ mu. Enti, ɛho hia paa sɛ wonya ayaresa wɔ bere ano. Sɛ biribi nti wuntumi nkɔ da a woahyɛ da ato hɔ no a, frɛ wo duruyɛfo anaa ayaresabea ntɛm ara na ma wɔnhu, sɛnea ɛbɛyɛ a wobetumi ayɛ nhyehyɛe ama da a edi hɔ a ɛwɔ hɔ no.

⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

Wɔnnya nyɛɛ nsɛm biara. Fa wo nsɛm no ka ho wɔ ha nea edi kan.

Fa wo nsɛm no ka ho

Yɛsrɛ wo bu akontaa: 1 + 5 =